Literature DB >> 10749994

Nuclear targeting defect of SMN lacking the C-terminus in a mouse model of spinal muscular atrophy.

T Frugier1, F D Tiziano, C Cifuentes-Diaz, P Miniou, N Roblot, A Dierich, M Le Meur, J Melki.   

Abstract

Deletion of the murine survival of motor neuron gene (SMN) exon 7, the most frequent mutation found in spinal muscular atrophy (SMA) patients, directed to neurons but not to skeletal muscle, enabled generation of a mouse model of SMA providing evidence that motor neurons are the primary target of the gene defect. Moreover, the mutated SMN protein (SMNDeltaC15) is dramatically reduced in the motor neuron nuclei and causes a lack of gems associated with large aggregates of coilin, a coiled-body-specific protein. These results identify the lack of the nuclear targeting of SMN as the biochemical defect in SMA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10749994     DOI: 10.1093/hmg/9.5.849

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  80 in total

1.  Post-transcriptional modification of spliceosomal RNAs is normal in SMN-deficient cells.

Authors:  Svetlana Deryusheva; Maria Choleza; Adrien Barbarossa; Joseph G Gall; Rémy Bordonné
Journal:  RNA       Date:  2011-11-28       Impact factor: 4.942

Review 2.  Spinal muscular atrophy: new and emerging insights from model mice.

Authors:  Gyu-Hwan Park; Shingo Kariya; Umrao R Monani
Journal:  Curr Neurol Neurosci Rep       Date:  2010-03       Impact factor: 5.081

3.  Reorganization of Cajal bodies and nucleolar targeting of coilin in motor neurons of type I spinal muscular atrophy.

Authors:  Olga Tapia; Rocío Bengoechea; Ana Palanca; Rosa Arteaga; J Fernando Val-Bernal; Eduardo F Tizzano; María T Berciano; Miguel Lafarga
Journal:  Histochem Cell Biol       Date:  2012-02-01       Impact factor: 4.304

4.  Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells.

Authors:  Zizhen Kang; Chenhui Wang; Jarod Zepp; Ling Wu; Kevin Sun; Junjie Zhao; Unni Chandrasekharan; Paul E DiCorleto; Bruce D Trapp; Richard M Ransohoff; Xiaoxia Li
Journal:  Nat Neurosci       Date:  2013-09-01       Impact factor: 24.884

5.  Low levels of Survival Motor Neuron protein are sufficient for normal muscle function in the SMNΔ7 mouse model of SMA.

Authors:  Chitra C Iyer; Vicki L McGovern; Jason D Murray; Sara E Gombash; Phillip G Zaworski; Kevin D Foust; Paul M L Janssen; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2015-08-13       Impact factor: 6.150

6.  Coilin forms the bridge between Cajal bodies and SMN, the spinal muscular atrophy protein.

Authors:  M D Hebert; P W Szymczyk; K B Shpargel; A G Matera
Journal:  Genes Dev       Date:  2001-10-15       Impact factor: 11.361

7.  Refined characterization of the expression and stability of the SMN gene products.

Authors:  Jérémie Vitte; Coralie Fassier; Francesco D Tiziano; Cécile Dalard; Sabrina Soave; Natacha Roblot; Christine Brahe; Pascale Saugier-Veber; Jean Paul Bonnefont; Judith Melki
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

Review 8.  Spinal muscular atrophy.

Authors:  Susan T Iannaccone; Stephen A Smith; Louise R Simard
Journal:  Curr Neurol Neurosci Rep       Date:  2004-01       Impact factor: 5.081

Review 9.  Animal models for metabolic, neuromuscular and ophthalmological rare diseases.

Authors:  Guillaume Vaquer; Frida Rivière; Maria Mavris; Fabrizia Bignami; Jordi Llinares-Garcia; Kerstin Westermark; Bruno Sepodes
Journal:  Nat Rev Drug Discov       Date:  2013-03-15       Impact factor: 84.694

10.  Molecular and phenotypic reassessment of an infrequently used mouse model for spinal muscular atrophy.

Authors:  Rocky G Gogliotti; Suzan M Hammond; Cathleen Lutz; Christine J Didonato
Journal:  Biochem Biophys Res Commun       Date:  2009-12-04       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.